Alphabet-A
GOOGL
Alphabet-C
GOOG
MicroStrategy
MSTR
Tesla
TSLA
Ecopetrol
EC
US Stock MarketDetailed Quotes
BCRX BioCryst Pharmaceuticals
- 7.930
- +0.200+2.59%
Close Dec 10 16:00 ET
- 7.990
- +0.060+0.76%
Pre 08:37 ET
1.64BMarket Cap-13.00P/E (TTM)
8.000High7.679Low1.77MVolume7.750Open7.730Pre Close13.92MTurnover0.92%Turnover RatioLossP/E (Static)207.13MShares8.88052wk High-3.51P/B1.53BFloat Cap4.03052wk Low--Dividend TTM193.36MShs Float37.250Historical High--Div YieldTTM4.16%Amplitude0.600Historical Low7.864Avg Price1Lot Size
About BioCryst Pharmaceuticals Company
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Company Profile
SymbolBCRX
Company NameBioCryst Pharmaceuticals
Listing DateMar 3, 1994
Issue Price6.50
Founded1986
CEOMr. Jon P. Stonehouse
MarketNASDAQ
Employees536
Fiscal Year Ends12-31
Address4505 Emperor Boulevard,Suite 200
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27703-8457
Phone1-919-859-1302
Websitehttp://www.biocryst.com
Company Executives
- Name
- Position
- Salary
- Jon P. Stonehouse
- Director, President and Chief Executive Officer
- 4.78M
- Alane Barnes
- Chief Legal Officer and Corporate Secretary
- 1.93M
- Dr. Helen M. Thackray, M.D.
- Chief Research and Development Officer
- 2.39M
- Charles K. Gayer
- Chief Commercial Officer
- 1.74M
- Anthony Doyle
- Chief Financial Officer, Treasurer and Interim Principal Accounting Officer
- 1.79M
- Dr. Nancy J. Hutson, PhD
- Chairman of the Board
- 470.30K
- Theresa M. Heggie
- Independent Director
- 433.57K
- Dr. Steven Galson, M.D.
- Independent Director
- 424.40K
- Dr. Amy McKee
- Independent Director
- 422.32K
- Machelle Sanders
- Independent Director
- 423.15K
- Vincent J. Milano
- Independent Director
- 434.82K
- Alan G. Levin
- Independent Director
- 434.54K
- Stephen J. Aselage
- Independent Director
- 446.90K
- George B. Abercrombie
- Independent Director
- 432.74K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.